A Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers

NCT03322800 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AK0529
OTHER: Placebo

Sponsor

Shanghai Ark Biopharmaceutical Co., Ltd.